Nine-month Humira sales fell 35.4%, but AbbVie (ABBV) earnings rose.

Stocks Stock Titan By Stock Titan 03 Nov 2026 18:44 1 min read
Nine-month Humira sales fell 35.4%, but AbbVie (ABBV) earnings rose.

Nine-month Humira sales fell 35.4%, but AbbVie (ABBV) earnings rose.  Stock Titan

Covered in this story

Call it yourself

No calls on $NINE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Nine Energy Service →
Read the full story on Stock Titan → Opens the original article on news.google.com

Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.